TNYA Tenaya Therapeutics, Inc.

BEARISH Impact: 4/10 Institutional Cluster
Horizon weeks Processed 2d 16h ago
Institutional cluster: 4 buyers, 2 sellers (mixed)

Executive Summary

Tenaya Therapeutics (TNYA) institutional cluster for Q3 2024 shows net distributing activity, with Adage Capital Partners trimming 67.6% of its position (from 1M to 324K shares, reducing value by $2.47M), while four smaller buyers added modestly (net $73K increase). The heavy selling by a top holder signals diminished institutional conviction in near-term prospects.

Key Financial Metrics

Direction
distributing
Buy Value
$322.0K
Sell Value
$3.1M
Net Flow
-$2.4M

Institutional Positions

Net institutional flow: -$2.4M

▲ Buyers (4)

InstitutionActionChangePosition ValueValue Δ
Panagora Asset Management DOUBLED +147.5% $252.0K $88.0K

▼ Sellers (2)

InstitutionActionChangePrev ValueValue Δ
Adage Capital Partners Gp TRIM -67.6% $3.1M -$2.5M

Actionable Insight

The dominant seller's large trim suggests waning confidence; monitor upcoming clinical catalysts and any financing updates. The 45-day 13F lag means positions may have changed further since quarter-end.

Key Facts

  • Adage Capital Partners reduced holdings by 675,755 shares (-67.6%), liquidating ~$2.47M of value.
  • Panagora Asset Management doubled its position (52.7K to 130.5K shares), adding ~$88K in current value.
  • Net institutional dollar change across the cluster is -$2.4M (sellers $2.47M removed vs buyers $73K added).
  • Buying was limited to small asset managers; no activist or high-conviction funds appeared on the buy side.

Financial Impact

Institutional cluster net selling of ~$2.4M, led by Adage Capital Partners' $2.47M reduction; buying totaled only $73K.

institutional position valueshareholder composition

Risk Factors

  • 13F data is 45 days stale; current institutional positions may differ materially.
  • Low trading volume could amplify any selling pressure if the trim continues.
  • Biotech small-cap with pre-revenue status carries high binary risk on pipeline events.

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
93% bullish (14 analysts)

Documents Analyzed

This report is based on 1 institutional 13F filing from SEC EDGAR.

DocumentAccession Number
INST-CLUSTER Data (Synthetic)inst-cluster-TNYA-2024-Q3
10 reports for TNYA
Performance horizon
33% Hit rate 1 of 3 directional calls best @ T+5▲ +9.04%Mar 5, 2026
Filters
Rows
Reports for TNYA — sortable, filterable
Type Now
Jun 12, 2026
2d ago
Institutional Cluster
BEARISH ★ 4/10
$0.7085 awaiting T+5awaiting T+5
May 29, 2026
16d ago
8-K
NEUTRAL ★ 3/10
$0.8700 $0.7280▼ −16.32%▼ −13.57%
May 19, 2026
26d ago
Insider Cluster
NEUTRAL ★ 2/10
$0.8080 $0.7920▼ −1.98%▼ −3.22%
May 16, 2026
29d ago
ANALYST-UPGRADE
BULLISH ★ 1/10
$3.76 $3.30▼ −12.23%▼ −14.36%
Apr 16, 2026
8w ago
ANALYST-UPGRADE
MIXED ★ 1/10
$0.7820 $0.6720▼ −14.07%▼ −14.62%
Apr 16, 2026
8w ago
DEFA14A
NEUTRAL ★ 3/10
$0.7470 $0.6840▼ −8.43%▼ −9.42%
Mar 11, 2026
13w ago
8-K
NEUTRAL ★ 4/10
$0.8930 $0.8040▼ −9.97%▼ −8.99%
Mar 11, 2026
13w ago
Press Release
MIXED ★ 6/10
$0.8930 $0.8040▼ −9.97%▼ −8.99%
Mar 9, 2026
13w ago
Press Release
BULLISH ★ 7/10
$0.9580 $0.8570▼ −10.54%▼ −9.19%
Mar 5, 2026
14w ago
8-K
BULLISH ★ 8/10
$0.8190 $0.8930▲ +9.04%▲ +11.27%
Showing 10 of 10

US Market Status

Market Closed — Opens in 3h 56m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access